Menu
  • Video
  • Audio
  • Images
  • Collections
  • About
Sign in
ASRS A project from the American Soceity of Retina Specialists
Share feedback      Sign in
ASRS Multimedia Library
ASRS A project from the American Society of Retina Specialists
Search by condition, keyword, or author name
  • Video
  • Audio
  • Images
  • Collections
  • About
  1. Collections
  2. Updates from the Field

Sign in to view content

Sign in

Brolucizumab for Neovascular AMD: The 2 Year HAWK and HARRIER Results

  • Pravin U. Dugel, MD
  • Video
  • Published 2018

Related

  • Open-Label Study Evaluating the Effects of the CCR3 Antagonist ALK4290 in Patients With Neovascular AMD Refractory to Anti-VEGF Therapy

    Michael W. Stewart, MD

    Annual Meeting Talks

    2019

  • The Changing Avastin Landscape

    Paul Hahn, MD, PhD, FASRS

    Annual Meeting Talks

    2019

  • Brolucizumab for the Treatment of Visual Impairment Due to Diabetic Macular Edema: 52-Week Results From the KESTREL and KITE Studies

    David M. Brown, MD

    Annual Meeting Talks

    2021

Category: AMD-Neovascular

  • Pharmacology
  • brolucizumab
  • Neovascualar AMD Clinical Trials

See more

  • Updates from the Field
  • Pravin U. Dugel, MD
  • ASRS Multimedia Library
  • Video
  • Audio
  • Images
  • Collections
American Society of Retina Specialists20 North Wacker Drive, Suite 2030,Chicago, Illinois 60606(312) 578-8760 phoneinfo@asrs.org
© 2023 The American Society of Retina Specialists. All rights reserved. Privacy statement. Terms of use.